Cigna Corporation logo

Cigna Corporation

CI

NYSEHealthcareMedical - Healthcare Plans

Previous close

$277.51

+$3.10 · +1.13%

Aug 21, 4:00 PM ET

CI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

96

Deep Value

Momentum

44

Neutral

Sentiment

61

Bullish

Risk resilience

82

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

Industry
Medical - Healthcare Plans
Sector
Healthcare
Headquarters
US
CEO
Brian C. Evanko
Listed since
Mar 31, 1982
Employees
66,685

Market position

Day range

Current $277.51

52-week range

Current $277.51

Open
$274.79
Previous close
$274.41
Volume
1.07M
0.63× average
Average volume
1.7M
Average daily volume
Market cap
73.33B USD
Beta
0.32
Market reference 1
50-day average
$284.68
-2.52% below average
200-day average
$278.81
-0.46% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
96.98B USD
P/E (TTM)
11.44×
P/B (TTM)
1.72×
P/S (TTM)
0.26×
EV / EBITDA
8.36×
Earnings yield
8.14%
Free cash flow yield
11.46%
Dividend yield
2.21%

Profitability & efficiency

Gross margin
11.66%
Operating margin
3.46%
Net margin
2.27%
Return on equity
14.28%
Return on assets
3.77%
Return on invested capital
7.35%

Financial health

Debt / equity
0.75×
Current ratio
0.85×
Altman Z-score
2.77
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends14%10%5%0%Gross margin, FY2021: 13.19%Gross margin, FY2022: 13.02%Gross margin, FY2023: 12.89%Gross margin, FY2024: 10.51%Gross margin, FY2025: 9.45%Operating margin, FY2021: 4.56%Operating margin, FY2022: 4.68%Operating margin, FY2023: 4.37%Operating margin, FY2024: 3.81%Operating margin, FY2025: 3.32%Net margin, FY2021: 3.08%Net margin, FY2022: 3.71%Net margin, FY2023: 2.64%Net margin, FY2024: 1.39%Net margin, FY2025: 2.17%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 13.19%. Gross margin FY2022 13.02%. Gross margin FY2023 12.89%. Gross margin FY2024 10.51%. Gross margin FY2025 9.45%. Operating margin FY2021 4.56%. Operating margin FY2022 4.68%. Operating margin FY2023 4.37%. Operating margin FY2024 3.81%. Operating margin FY2025 3.32%. Net margin FY2021 3.08%. Net margin FY2022 3.71%. Net margin FY2023 2.64%. Net margin FY2024 1.39%. Net margin FY2025 2.17%.

Income trends

Revenue

274.95B USD+11.26%

Operating income

9.13B USD-3.06%

Net income

5.96B USD+73.47%
Income trends across reported periods302.1B USD193.5B USD84.89B USD−23.72B USDRevenue, FY2021: 174.07B USDRevenue, FY2022: 180.52B USDRevenue, FY2023: 195.27B USDRevenue, FY2024: 247.12B USDRevenue, FY2025: 274.95B USDOperating income, FY2021: 7.94B USDOperating income, FY2022: 8.45B USDOperating income, FY2023: 8.54B USDOperating income, FY2024: 9.42B USDOperating income, FY2025: 9.13B USDNet income, FY2021: 5.37B USDNet income, FY2022: 6.7B USDNet income, FY2023: 5.16B USDNet income, FY2024: 3.43B USDNet income, FY2025: 5.96B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 174.07B USD. Revenue FY2022 180.52B USD. Revenue FY2023 195.27B USD. Revenue FY2024 247.12B USD. Revenue FY2025 274.95B USD. Operating income FY2021 7.94B USD. Operating income FY2022 8.45B USD. Operating income FY2023 8.54B USD. Operating income FY2024 9.42B USD. Operating income FY2025 9.13B USD. Net income FY2021 5.37B USD. Net income FY2022 6.7B USD. Net income FY2023 5.16B USD. Net income FY2024 3.43B USD. Net income FY2025 5.96B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue274.95B USD247.12B USD195.27B USD180.52B USD174.07B USD
Cost of goods sold248.97B USD221.16B USD170.09B USD157.02B USD151.12B USD
Gross profit25.99B USD25.96B USD25.18B USD23.5B USD22.95B USD
Selling, general, and administrative14B USD14.57B USD14.32B USD13.05B USD12.79B USD
Operating expenses16.86B USD16.55B USD16.64B USD15.05B USD15.01B USD
Interest expense1.38B USD1.44B USD1.45B USD1.23B USD1.21B USD
Depreciation and amortization2.63B USD1.75B USD1.81B USD1.86B USD1.8B USD
Operating income9.13B USD9.42B USD8.54B USD8.45B USD7.94B USD
Net income5.96B USD3.43B USD5.16B USD6.7B USD5.37B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 1 miss, 0 met estimates
Average EPS surprise
+1.62%
11 comparable reports
Latest EPS result
7.78
Estimate 7.6 · Beat by 2.37%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates8.47.616.826.03Q1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 30, 2025: actual 6.64, estimate 7.84, surprise -15.31%, Miss. Q2 2025, reported May 2, 2025: actual 6.74, estimate 6.35, surprise +6.14%, Beat. Q3 2025, reported Jul 31, 2025: actual 7.2, estimate 7.16, surprise +0.56%, Beat. Q4 2025, reported Oct 30, 2025: actual 7.83, estimate 7.64, surprise +2.49%, Beat. Q1 2026, reported Feb 5, 2026: actual 8.08, estimate 7.88, surprise +2.54%, Beat. Q2 2026, reported Apr 30, 2026: actual 7.79, estimate 7.6, surprise +2.50%, Beat. Q3 2026, reported Jul 30, 2026: actual 7.78, estimate 7.6, surprise +2.37%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 7.49, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates75.57B69.48B63.38B57.29BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 30, 2025: actual 65.72B USD, estimate 63.44B USD, surprise +3.59%, Beat. Q2 2025, reported May 2, 2025: actual 65.5B USD, estimate 60.2B USD, surprise +8.81%, Beat. Q3 2025, reported Jul 31, 2025: actual 67.23B USD, estimate 62.91B USD, surprise +6.87%, Beat. Q4 2025, reported Oct 30, 2025: actual 69.75B USD, estimate 67.58B USD, surprise +3.21%, Beat. Q1 2026, reported Feb 5, 2026: actual 72.47B USD, estimate 70.31B USD, surprise +3.08%, Beat. Q2 2026, reported Apr 30, 2026: actual 68.49B USD, estimate 66.29B USD, surprise +3.32%, Beat. Q3 2026, reported Jul 30, 2026: actual 71.67B USD, estimate 70.14B USD, surprise +2.17%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 72.66B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$338.33

21.92% upside
Past 12 months12-month forecastHigh $400Average $338.33Low $302

Rating distribution

39 ratings
Strong buy00%
Buy2974%
Hold1026%
Sell00%
Strong sell00%

Recent analyst actions

12 institutions

CI news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$6.04

2025 complete year+51.0% since 2021

2026 partial: $3.12

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 8, 2026

$1.56

Quarterly

Record Sep 8, 2026 · Payment Sep 23, 2026

Dividend

Ex-dividend Jun 4, 2026

$1.56

Quarterly

Record Jun 4, 2026 · Payment Jun 18, 2026

Dividend

Ex-dividend Mar 5, 2026

$1.56

Quarterly

Record Mar 5, 2026 · Payment Mar 19, 2026

Dividend

Ex-dividend Dec 4, 2025

$1.51

Quarterly

Record Dec 4, 2025 · Payment Dec 18, 2025

Dividend

Ex-dividend Sep 4, 2025

$1.51

Quarterly

Record Sep 4, 2025 · Payment Sep 18, 2025

Dividend

Ex-dividend Jun 3, 2025

$1.51

Quarterly

Record Jun 3, 2025 · Payment Jun 18, 2025

CI peers

ETFs holding CI

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research CI

research.disclaimer